1. LB4. Casirivimab and Imdevimab for Treatment of Hospitalized Patients With COVID-19 Receiving Low Flow or No Supplemental Oxygen. (4th December 2021) Authors: Mylonakis, Eleftherios; Somersan-Karakaya, Selin; Sivapalasingam, Sumathi; Ali, Shazia; Sun, Yiping; Bhore, Rafia; Mei, Jingning; Miller, Jutta; Cupelli, Lisa; Hooper, Andrea T; Hamilton, Jennifer D; Pan, Cynthia; Pham, Viet; Zhao, Yuming; Hosain, Romana; Mahmood, Adnan; Davis, John D; Turner, Ke... Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and tolerability of a 6‐week course of oseltamivir prophylaxis for seasonal influenza in children. Issue 1 (23rd April 2012) Authors: Reisinger, Keith; Shu, Daniel; Cupelli, Lisa; Marcadis, Isaac; Dutkowski, Regina Journal: Influenza and other respiratory viruses Issue: Volume 7:Issue 1(2013:Jan.) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗